Cargando…
The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
Inflammation-induced coagulopathy is a common complication associated with coronavirus disease 2019 (COVID-19). We aim to evaluate the association of NETosis and complement markers with each other as well as their association with thrombogenicity and disease severity in COVID-19. The study included...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216097/ https://www.ncbi.nlm.nih.gov/pubmed/37239041 http://dx.doi.org/10.3390/biomedicines11051371 |
_version_ | 1785048217070600192 |
---|---|
author | Ghanbari, Emily Parissa Jakobs, Kai Puccini, Marianna Reinshagen, Leander Friebel, Julian Haghikia, Arash Kränkel, Nicolle Landmesser, Ulf Rauch-Kröhnert, Ursula |
author_facet | Ghanbari, Emily Parissa Jakobs, Kai Puccini, Marianna Reinshagen, Leander Friebel, Julian Haghikia, Arash Kränkel, Nicolle Landmesser, Ulf Rauch-Kröhnert, Ursula |
author_sort | Ghanbari, Emily Parissa |
collection | PubMed |
description | Inflammation-induced coagulopathy is a common complication associated with coronavirus disease 2019 (COVID-19). We aim to evaluate the association of NETosis and complement markers with each other as well as their association with thrombogenicity and disease severity in COVID-19. The study included hospitalized patients with an acute respiratory infection: patients with SARS-CoV2 infection (COVpos, n = 47) or either pneumonia or infection-triggered acute exacerbated COPD (COVneg, n = 36). Our results show that NETosis, coagulation, and platelets, as well as complement markers, were significantly increased in COVpos patients, especially in severely ill COVpos patients. NETosis marker MPO/DNA complexes correlated with coagulation, platelet, and complement markers only in COVpos. Severely ill COVpos patients showed an association between complement C3 and SOFA (R = 0.48; p ≤ 0.028), C5 and SOFA (R = 0.46; p ≤ 0.038), and C5b-9 and SOFA (R = 0.44; p ≤ 0.046). This study provides further evidence that NETosis and the complement system are key players in COVID-19 inflammation and clinical severity. Unlike previous studies that found NETosis and complement markers to be elevated in COVID-19 patients compared to healthy controls, our findings show that this characteristic distinguishes COVID-19 from other pulmonary infectious diseases. Based on our results, we propose that COVID-19 patients at high risk for immunothrombosis could be identified via elevated complement markers such as C5. |
format | Online Article Text |
id | pubmed-10216097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102160972023-05-27 The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies Ghanbari, Emily Parissa Jakobs, Kai Puccini, Marianna Reinshagen, Leander Friebel, Julian Haghikia, Arash Kränkel, Nicolle Landmesser, Ulf Rauch-Kröhnert, Ursula Biomedicines Article Inflammation-induced coagulopathy is a common complication associated with coronavirus disease 2019 (COVID-19). We aim to evaluate the association of NETosis and complement markers with each other as well as their association with thrombogenicity and disease severity in COVID-19. The study included hospitalized patients with an acute respiratory infection: patients with SARS-CoV2 infection (COVpos, n = 47) or either pneumonia or infection-triggered acute exacerbated COPD (COVneg, n = 36). Our results show that NETosis, coagulation, and platelets, as well as complement markers, were significantly increased in COVpos patients, especially in severely ill COVpos patients. NETosis marker MPO/DNA complexes correlated with coagulation, platelet, and complement markers only in COVpos. Severely ill COVpos patients showed an association between complement C3 and SOFA (R = 0.48; p ≤ 0.028), C5 and SOFA (R = 0.46; p ≤ 0.038), and C5b-9 and SOFA (R = 0.44; p ≤ 0.046). This study provides further evidence that NETosis and the complement system are key players in COVID-19 inflammation and clinical severity. Unlike previous studies that found NETosis and complement markers to be elevated in COVID-19 patients compared to healthy controls, our findings show that this characteristic distinguishes COVID-19 from other pulmonary infectious diseases. Based on our results, we propose that COVID-19 patients at high risk for immunothrombosis could be identified via elevated complement markers such as C5. MDPI 2023-05-05 /pmc/articles/PMC10216097/ /pubmed/37239041 http://dx.doi.org/10.3390/biomedicines11051371 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ghanbari, Emily Parissa Jakobs, Kai Puccini, Marianna Reinshagen, Leander Friebel, Julian Haghikia, Arash Kränkel, Nicolle Landmesser, Ulf Rauch-Kröhnert, Ursula The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title | The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title_full | The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title_fullStr | The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title_full_unstemmed | The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title_short | The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies |
title_sort | role of netosis and complement activation in covid-19-associated coagulopathies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216097/ https://www.ncbi.nlm.nih.gov/pubmed/37239041 http://dx.doi.org/10.3390/biomedicines11051371 |
work_keys_str_mv | AT ghanbariemilyparissa theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT jakobskai theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT puccinimarianna theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT reinshagenleander theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT friebeljulian theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT haghikiaarash theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT krankelnicolle theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT landmesserulf theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT rauchkrohnertursula theroleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT ghanbariemilyparissa roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT jakobskai roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT puccinimarianna roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT reinshagenleander roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT friebeljulian roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT haghikiaarash roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT krankelnicolle roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT landmesserulf roleofnetosisandcomplementactivationincovid19associatedcoagulopathies AT rauchkrohnertursula roleofnetosisandcomplementactivationincovid19associatedcoagulopathies |